Research programme: Schisandra lignin therapy - China Botanic PharmaceuticalAlternative Names: Compound Schisandra Tablets - China Botanic Pharmaceutical; Schisandra lignin tablets - China Botanic Pharmaceutical; Schisandra-based insomnia therapy - China Botanic Pharmaceutical; Schizandra tablets - China Botanic Pharmaceutical
Latest Information Update: 16 Jul 2016
At a glance
- Originator China Botanic Pharmaceutical
- Class Kampo medicine; Traditional-Chinese-medicine
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Insomnia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Insomnia in China (PO, Tablet)
- 31 Jul 2011 Preclinical trials in Insomnia in China (PO)